Recognizing novel drugs against Keap1 in Alzheimer’s disease using machine learning grounded computational studies
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2022.1036552
Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, affecting an estimated 50 million individuals. The nerve cells become impaired and die due to the formation of amyloid-beta (Aβ) plaques and neurofibrillary… read more here.
Keywords: recognizing novel; disease; alzheimer disease; machine learning ... See more keywords